Initial report of a randomized trial of post-prostatectomy prostate cancer radiotherapy using either fluciclovine (18F) or PSMA (68Ga) PET/CT for target dose-escalation. This is an ASCO Meeting ...
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...
GlobalData on MSN1d
Telix’s prostate cancer imaging agent approved in BrazilBrazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...
One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...
SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Abhi Moolupuri discussing a PET/CT supplemented approach to omission of pelvic lymph node dissection. The National ...
30 patients of endometrial cancer were investigated and the FDG-PET imaging results were compared with CT and/or MRI and the results of postoperative histopathological results. [76] With regard to ...
Art of Healing Cancer, who explained what a full-body scan is, how it works, and what you should consider before opting for one. The whole body or PET CT scan is a comprehensive examination that ...
Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market. TAIPEI, Taiwan, March 19, 2025 (GLOBE ...
PET/CT is a useful tool to map out the possible sites where the cancer first originated. PET/CT is a form of hybrid imaging that combines computed tomography (CT), an anatomical imaging ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback